AKT1 and type 2 diabetes mellitus: PI3K-AKT signaling pathway (n = 45) and AGE-RAGE signaling pathway in diabetic complications (n = 35) enriched higher number of targets, and may be the important pathways in the treatment of JLD against T2DM.